Deals Today

	Click to View in Browser 04/3/2013 BP puts U.S. wind farm arm up for sale LONDON (Reuters) - BP has put its U.S. wind farm operation, one of the largest in the country, up for sale, marking the continued retreat of big oil companies from renewable energy investments while oil and gas projects offer them better returns. AstraZeneca buys early-stage U.S. biotech firm LONDON (Reuters) - AstraZeneca boosted its early-stage pipeline of experimental heart drugs on Wednesday by buying privately held U.S. biotechnology company AlphaCore Pharma, which is developing a new type of cholesterol medicine. Glencore pushes back Xstrata deal due to China probe LONDON (Reuters) - Glencore said on Tuesday it had again extended the date by which it expects to close its merger with Xstrata, due to the ongoing investigation into the deal in China. Royalty Pharma handed May deadline to make firm Elan offer DUBLIN (Reuters) - Investment firm Royalty Pharma must either announce an offer for Irish drugmaker Elan by May 10 or not proceed with a $6.6 billion approach, Ireland's Takeover Panel said on Wednesday. Vodafone shares drop after Verizon rules out takeover LONDON (Reuters) - Shares in Vodafone fell on Wednesday after Verizon Communications ruled out a full takeover, turning the focus yet again to whether the two telecom giants can do a deal over their Verizon Wireless joint venture. Areva sells Canberra unit to Astorg for undisclosed price PARIS (Reuters) - French nuclear reactor maker Areva said it had agreed to sell its nuclear radiation measurement unit, Canberra, to private equity group Astorg Partners for an undisclosed amount. Exclusive - Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources NEW YORK/LONDON (Reuters) - At least three of the world's top drugmakers are bidding for Brazil's Ache Laboratorios Farmaceuticos in an auction that may value the group at more than $5 billion, people familiar with the matter said. Tele2 sees further gains in $3.5 billion sale of Russia unit STOCKHOLM (Reuters) - Tele2 said it stood to gain more than the $3.5 billion price agreed for its Russian unit if the buyer sells it again within a year, as the Swedish telecoms group tries to fend off competing bids from industry rivals. Exclusive: Thermo emerges as frontrunner for Life Tech -sources NEW YORK (Reuters) - Thermo Fisher Scientific Inc is emerging as the lead contender in an auction for Life Technologies Corp , a genetic testing maker with a market value of more than $11 billion, three people familiar with the matter said this week. Baer says Merrill Lynch unit integration on track ZURICH (Reuters) - Julius Baer has transferred ownership of businesses in Chile, Uruguay, Monaco and Luxembourg which it bought from Merrill Lynch as it integrates the wealth management businesses it acquired from the U.S. bank. Related Video Reuters Breakingviews: Salz peppers Barclays with criticisms FACTBOX: North Korea slams door on South at shared factory Related News Analysis: Jobless youths could drag on recovery Apartment vacancy rate falls to lowest level since 2001 A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend